Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The global pipeline of GM crops out to 2020

Although a few arable crops and agronomic traits will likely dominate commercial varieties for the foreseeable future, with many being stacked together, more quality traits and specialty crops are being introduced into the pipeline.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: GM crop events in the market and at the precommercial, regulatory and advanced R&D stages in 2008 and 2014, illustrated by crop.
Figure 2: Distribution of traits among GM crop transformation events in commercial cultivation in 2008 and in 2014, and at the precommercial and regulatory stages in 2014.
Figure 3: Distribution of GM crop events per developer type and development phase.
Figure 4
Figure 5: Distribution of type of GM crops developed at different stages in industrialized and developing countries.
Figure 6: Number of commercial stacks identified per crop.


  1. James, C. Global Status of Commercialized Biotech/GM Crops: 2014. ISAAA Brief 49. (International Service for the Acquisition of Agri-Biotech Applications, Ithaca, NY, 2014).

  2. Miller, J.K. & Bradford, K.J. The regulatory bottleneck for biotech specialty crops. Nat. Biotechnol. 28, 1012–1014 (2010).

    Article  CAS  Google Scholar 

  3. Graff, G.D., Zilberman, D. & Bennett, A.B. The contraction of agbiotech product quality innovation. Nat. Biotechnol. 27, 702–704 (2009).

    Article  CAS  Google Scholar 

  4. Stein, A.J. & Rodriguez-Cerezo, E. The Global Pipeline of New GM Crops. Implications of Asynchronous Approval for International Trade (European Commission, Joint Research Centre, 2009).

    Google Scholar 

  5. Stein, A.J. & Rodríguez-Cerezo, E. International trade and the global pipeline of new GM crops. Nat. Biotechnol. 28, 23–25 (2010).

    Article  CAS  Google Scholar 

  6. Kalaitzandonakes, N., Alston, J.M. & Bradford, K.J. Compliance costs for regulatory approval of new biotech crops. Nat. Biotechnol. 25, 509–511 (2007).

    Article  CAS  Google Scholar 

  7. Waltz, E. Monsanto adds dicamba to its cache to counter weed threat. Nat. Biotechnol. 33, 328 (2015).

    Article  CAS  Google Scholar 

  8. Cockburn, A. Commercial plant breeding: What is in the biotech pipeline? J. Commer. Biotechnol. 10, 209–223 (2004).

    Article  Google Scholar 

  9. De Steur, H. et al. Status and market potential of transgenic biofortified crops. Nat. Biotechnol. 33, 25–29 (2015).

    Article  CAS  Google Scholar 

  10. Wolt, J.D. & Karaman, S. Estimated environmental loads of alpha-amylase from transgenic high-amylase maize. Biomass Bioenergy 31, 831–835 (2007).

    Article  CAS  Google Scholar 

  11. Harwood, J.L. et al. Regulation and enhancement of lipid accumulation in oil crops: The use of metabolic control analysis for informed genetic manipulation. Eur. J. Lipid Sci. Technol. 115, 1239–1246 (2013).

    Article  CAS  Google Scholar 

  12. Falck-Zepeda, J., Gruère, G. & Sithole-Niang, I. Genetically Modified Crops in Africa. Economic and Policy Lessons from Countries South of the Sahara (International Food Policy Research Institute, Washington, DC, 2013).

    Google Scholar 

  13. Huang, J., Rozelle, S., Pray, C. & Wang, Q. Plant biotechnology in China. Science 295, 674–676 (2002).

    Article  CAS  Google Scholar 

  14. Atanassov, A. et al. To Reach the Poor: Results from the ISNAR-IFPRI Next Harvest Study on Genetically Modified Crops, Public Research, and Policy Implications (Environment and Production Technology Division, International Food Policy Research Institute, Washington, DC, 2004).

    Google Scholar 

  15. ISAAA. Pocket K No. 42: Stacked Traits in Biotech Crops. (International Service for the Acquisition of Agri-Biotech Applications, Ithaca, NY, 2013).

  16. European Commission. CO-EXTRA: GM and Non-GM Supply Chains: Their CO-EXistence and TRAceability. Deliverable D6.4. (EC, Sixth Framework Programme, 2008).

  17. De Schrijver, A. et al. Risk assessment of GM stacked events obtained from crosses between GM events. Trends Food Sci. Technol. 18, 101–109 (2007).

    Article  CAS  Google Scholar 

  18. EuropaBio. Approvals of GMOs in the European Union (European Association of Bioindustries, Brussels; 2011).

  19. Kalaitzandonakes, N., Kaufman, J. & Miller, D. Potential economic impacts of zero thresholds for unapproved GMOs: the EU case. Food Policy 45, 146–157 (2014).

    Article  Google Scholar 

  20. FAO. Technical Consultation on Low Levels of GM Crops in International Food and Feed Trade. Food and Agriculture Organization of the United Nations. Rome, Italy, 20–21 March 2014.

  21. Grushkin, D. Threat to global GM soybean access as patent nears expiry. Nat. Biotechnol. 31, 10–11 (2013).

    Article  CAS  Google Scholar 

  22. Conko, G. Is There a Future for generic Biotech Crops? Regulatory Reform is Needed for a Viable Post-Patent Industry. Issue Analysis 2012 No. 7. (Competitive Enterprise Institute, 2012).

  23. Koch, A. et al. Host-induced gene silencing of cytochrome P450 lanosterol C14a-demethylase-encoding genes confers strong resistance to Fusarium species. Proc. Natl. Acad. Sci. USA 110, 19324–19329 (2013).

    Article  CAS  Google Scholar 

  24. Mao, Y.-B., Tao, X.-Y., Xue, X.-Y., Wang, L.-J. & Chen, X.-Y. Cotton plants expressing CYP6AE14 double-stranded RNA show enhanced resistance to bollworms. Transgenic Res. 20, 665–673 (2011).

    Article  CAS  Google Scholar 

  25. Gil-Humanes, J., Pistón, F., Tollefsen, S., Sollid, L.M. & Barro, F. Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference. Proc. Natl. Acad. Sci. USA 107, 17023–17028 (2010).

    Article  CAS  Google Scholar 

  26. Dodo, H.W., Konan, K.N., Chen, F.C., Egnin, M. & Viquez, O.M. Alleviating peanut allergy using genetic engineering: the silencing of the immunodominant allergen Ara h 2 leads to its significant reduction and a decrease in peanut allergenicity. Plant Biotechnol. J. 6, 135–145 (2008).

    Article  CAS  Google Scholar 

  27. Lusser, M., Parisi, C., Plan, D. & Rodríguez-Cerezo, E. Deployment of new biotechnologies in plant breeding. Nat. Biotechnol. 30, 231–239 (2012).

    Article  CAS  Google Scholar 

  28. Lusser, M., Parisi, C., Plan, D. & Rodríguez-Cerezo, E. New Plant Breeding Techniques. State-of-the-Art and Prospects for Commercial Development. JRC Technical Report EUR 24760 EN. (European Commission. Joint Research Centre, 2011).

Download references


The authors wish to thank all the participants in the International Workshop on the Global Pipeline of GM crops that took place in Seville, at the JRC-IPTS (Institute for Prospective Technological Studies) premises, on June 11 and 12, 2014, for their active participation and their contribution to the description of the GM crops pipeline.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Claudia Parisi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Source data

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Parisi, C., Tillie, P. & Rodríguez-Cerezo, E. The global pipeline of GM crops out to 2020. Nat Biotechnol 34, 31–36 (2016).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing